Fairvalue-Calculator Fairvalue-Calculator
EN DE

Memphasys Limited (MEM) Fair Value & Analysis

Healthcare · AU · Market cap A$14.2M

PriceA$0.0070
Fair ValueA$0.0072
Upside+3.0%
Quality95/100
Evidence: Low

Fair value as of: Jun 26, 2026

Analysis

Memphasys Limited (MEM) currently trades at A$0.0070, while our model-based Fair Value estimate is A$0.0072 — implying the stock looks roughly 3.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is Memphasys Limited (MEM) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.0072 versus a price of A$0.0070 — about +3% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MEM?
Our 21-model fair value for Memphasys Limited is A$0.0072 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.0070.
What is the quality score of MEM?
Memphasys Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.